ZAI LAB LTD's ticker is ZLAB and the CUSIP is 98887Q104. A total of 218 filers reported holding ZAI LAB LTD in Q1 2021. The put-call ratio across all filers is 0.90 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $398,802 | +134630.4% | 13,027 | +35.3% | 0.00% | 0.0% |
| Q4 2022 | $296 | -99.9% | 9,627 | +23.0% | 0.00% | 0.0% |
| Q3 2022 | $273,000 | +5.0% | 7,827 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $260,000 | -24.6% | 7,827 | -10.3% | 0.00% | 0.0% |
| Q1 2022 | $345,000 | -32.4% | 8,727 | -5.4% | 0.00% | 0.0% |
| Q4 2021 | $510,000 | -35.8% | 9,227 | +5.7% | 0.00% | 0.0% |
| Q3 2021 | $794,000 | -54.5% | 8,727 | -25.3% | 0.00% | -66.7% |
| Q2 2021 | $1,745,000 | +1.3% | 11,690 | -22.9% | 0.00% | 0.0% |
| Q1 2021 | $1,722,000 | -19.8% | 15,167 | -21.8% | 0.00% | -25.0% |
| Q4 2020 | $2,146,000 | +77.9% | 19,400 | +14.1% | 0.00% | +100.0% |
| Q3 2020 | $1,206,000 | +14.5% | 17,000 | +18.1% | 0.00% | 0.0% |
| Q2 2020 | $1,053,000 | +20.2% | 14,400 | -15.3% | 0.00% | +100.0% |
| Q1 2020 | $876,000 | – | 17,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Genesis Investment Management, LLP | 1,032,166 | $25,091,955 | 3.50% |
| XY Capital Ltd | 139,743 | $3,397,152 | 1.95% |
| Paradigm Biocapital Advisors LP | 1,142,383 | $27,771,331 | 1.88% |
| Privium Fund Management B.V. | 240,683 | $5,851,004 | 1.74% |
| Segantii Capital Management Ltd | 1,788,999 | $43,262,801 | 1.52% |
| Vivo Capital, LLC | 454,606 | $11,051,472 | 1.21% |
| BRILLIANCE ASSET MANAGEMENT LTD | 157,085 | $3,818,736 | 0.96% |
| Capricorn Fund Managers Ltd | 100,967 | $2,454,508 | 0.85% |
| Rock Springs Capital Management LP | 1,237,023 | $30,072,029 | 0.81% |
| Long Corridor Asset Management Ltd | 31,000 | $753,610 | 0.66% |